About UPCI
Administration
UPCI Shared Facility Directors
The shared resources at UPCI include state-of-the-art facilities that provide infrastructure, technology, support, and expertise to enhance basic, translational, and clinical cancer research with a goal to provide outstanding service at reasonable cost. In addition to standard service offerings, most facilities will also work with researchers to provide customized procedures as needed. Facility Directors provide expert consultation and, in some cases, may participate as co-investigators on research faculty grants.
| Carolyn Anderson, PhD | Co-Director, In Vivo Imaging Facility (IVIF); Leader, Preclinical PET/CT Modality |
| Per Basse, MD, PhD, DMSci | Assistant Director, Cell and Tissue Imaging Facility (CTIF), Hillman Satellite |
| Michael Becich, MD, PhD | Co-Director, Cancer Informatics Services (CIS) |
| Jan Hendrik Beumer, PharmD, PhD | Director, Clinical Pharmacology Analytical Facility (CPAF) |
| Lisa Butterfield, PhD | Director, Immunologic Monitoring and Cellular Products Laboratory (IMCPL) |
| Uma Chandran, PhD | Co-Director, Cancer Informatics Services (CIS) |
| Deidre Cleary, RN, BSN, CCRC | Director, Clinical Research Services (CRS) |
| Rajiv Dhir, MD | Director, Tissue and Research Pathology Services (TARPS) |
| Albert Donnenberg, PhD | Co-Director, Cytometry Facility (CF); Leader, Flow and ImageStream Platform |
| Andrea Gambotto, MD | Co-Director, Vector Core Facility (VCF); Leader, Adenovirus/Retrovirus Services |
| Susanne Gollin, PhD, FACMG | Director, Cell Culture and Cytogenetics Facility |
| Frank Jenkins, PhD | Director, Biobehavioral Medicine Facility |
| William LaFramboise, PhD | Co-Director, Cancer Biomarkers Facility (CBF) |
| Anna Lokshin, PhD | Leader, Luminex Platform (CBF) |
| Michael Lotze, MD | Co-Director, Cytometry Facility (CF); Leader, ArrayScan Platform |
| Brian Miller, PharmD | Director, Investigational Drug Services (IDS) |
| James Mountz, MD, PhD | Co-Director, In Vivo Imaging Facility (IVIF); Leader, PET/CT and Clinical MRI Modalities |
| Joseph T. Newsome, DVM, DACLAM | Director, Animal Facility (AF) |
| Daniel P. Normolle, PhD | Director, Biostatistics Facility (BF) |
| Marjorie Romkes, PhD | Leader, Illumina Platform (CBF) |
| John Schmitz, PhD | Director, Translational Research Facility |
| Robert Sobol, PhD | Co-Director, Vector Core Facility (VCF); Leader, Lentivirus Service |
| Lansing Taylor, PhD | Director, Chemical Biology Facility (ChBF) |
| Stephen Thorne, PhD | Leader, Small Animal Optical and Ultrasound Modality (IVIF) |
| Simon Watkins, PhD | Director, Cell and Tissue Imaging Facility (CTIF) |
| Erik Wiener, PhD | Leader, Preclinical MRI Modality (IVIF) |
| Nathan Yates, PhD | Co-Director, Cancer Biomarkers Facility (CBF) |
